Norah Palmateer
Datos Biográficos
| ID | 6082453 |
|---|---|
| NOMBRE | Norah Palmateer |
| NOMBRES | Norah |
| APELLIDO | Palmateer |
| FIRMA | PALMATEER N |
| AFILIACIONES | Vivian D. Hope, Andrea Marongiu, Joanne White, and Fortune Ncube are with Health Protection Services, Health Protection Agency, London, UK. Norah Palmateer and David Goldberg are with Health Protection Scotland, Glasgow, UK. Lucas Wiessing is with the European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal. |
| VERIFICADO | No |
| TOTAL DE OBRAS | 12 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 12 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2011 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Drug-related death rates associated with prescribed and illicit benzodiazepine exposure among people receiving opioid-agonist treatment in Scotland, 2015 to 2020
BACKGROUND: Opioid agonist treatment (OAT) reduces mortality among individuals with opioid dependence. Benzodiazepine co-prescribing with OAT has previously been associated with increased rates of drug-related death (DRD). In Scotland, rising DRD rates have coincided with increasing detection of illicit benzodiazepines at post-mortem. We quantified DRD rates associated with prescribed and baseline self-reported illicit benzodiazepine exposure amo…
Risk of drug-related mortality among people receiving opioid-agonist treatment during the Covid-19 pandemic in Scotland
During the COVID-19 pandemic in Scotland, DRD rates remained stable following a three-fold rise since 2011-13. The protective effect of OAT was sustained during the pandemic, which highlights the importance of maintaining access to OAT during public health crises
Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK
Real-world evidence showing substantial reductions in chronic HCV associated with increase of HCV treatment scale-up in the community thus supporting the effectiveness of HCV treatment as prevention in people who inject drugs
Sars-CoV-2 vaccine uptake and risks of severe Covid-19 disease among people prescribed opioid agonist therapy in Scotland
BACKGROUND: There is limited evidence quantifying the risk of severe COVID-19 disease among people with opioid dependence. We examined vaccine uptake and severe disease (admission to critical care or death with COVID-19) among individuals prescribed opioid agonist therapy (OAT). METHOD: A case-control design was used to examine vaccine uptake in those prescribed OAT compared with the general population, and the association between severe disease …
The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in Scotland
Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era
Spore forming bacteria infections and people who inject drugs
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs
Interventions to prevent HIV and Hepatitis C in people who inject drugs
A Decade of Spore-Forming Bacterial Infections Among European Injecting Drug Users
The recent anthrax outbreak among injecting drug users (IDUs) in Europe has highlighted an ongoing problem with severe illness resulting from spore-forming bacteria in IDUs. We collated the numbers of cases of 4 bacterial illnesses (botulism, tetanus, Clostridium novyi, and anthrax) in European IDUs for 2000 to 2009 and calculated population rates. Six countries reported 367 cases; rates varied from 0.03 to 7.54 per million people. Most cases (92…
Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users
P1-44 Application of a novel method to estimate incidence of hepatitis C among injecting drug users in Scotland
Background Prevalence of the hepatitis C virus (HCV) among injecting drug users (IDUs) in Scotland is high. Through an HCV Action Plan, the Scottish Government has invested significantly in harm reduction interventions with the goal of reducing HCV transmission among IDUs. In evaluating the effectiveness of interventions, estimates of the incidence, rather than the prevalence, of HCV are essential. The traditional approach to measuring incidence—…
Sin obras prominentes en esta página.
Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users
P1-44 Application of a novel method to estimate incidence of hepatitis C among injecting drug users in Scotland
Background Prevalence of the hepatitis C virus (HCV) among injecting drug users (IDUs) in Scotland is high. Through an HCV Action Plan, the Scottish Government has invested significantly in harm reduction interventions with the goal of reducing HCV transmission among IDUs. In evaluating the effectiveness of interventions, estimates of the incidence, rather than the prevalence, of HCV are essential. The traditional approach to measuring incidence—…
A Decade of Spore-Forming Bacterial Infections Among European Injecting Drug Users
The recent anthrax outbreak among injecting drug users (IDUs) in Europe has highlighted an ongoing problem with severe illness resulting from spore-forming bacteria in IDUs. We collated the numbers of cases of 4 bacterial illnesses (botulism, tetanus, Clostridium novyi, and anthrax) in European IDUs for 2000 to 2009 and calculated population rates. Six countries reported 367 cases; rates varied from 0.03 to 7.54 per million people. Most cases (92…
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs
Interventions to prevent HIV and Hepatitis C in people who inject drugs
Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era
Spore forming bacteria infections and people who inject drugs
The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in Scotland
Sars-CoV-2 vaccine uptake and risks of severe Covid-19 disease among people prescribed opioid agonist therapy in Scotland
BACKGROUND: There is limited evidence quantifying the risk of severe COVID-19 disease among people with opioid dependence. We examined vaccine uptake and severe disease (admission to critical care or death with COVID-19) among individuals prescribed opioid agonist therapy (OAT). METHOD: A case-control design was used to examine vaccine uptake in those prescribed OAT compared with the general population, and the association between severe disease …
Risk of drug-related mortality among people receiving opioid-agonist treatment during the Covid-19 pandemic in Scotland
During the COVID-19 pandemic in Scotland, DRD rates remained stable following a three-fold rise since 2011-13. The protective effect of OAT was sustained during the pandemic, which highlights the importance of maintaining access to OAT during public health crises
Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK
Real-world evidence showing substantial reductions in chronic HCV associated with increase of HCV treatment scale-up in the community thus supporting the effectiveness of HCV treatment as prevention in people who inject drugs
Drug-related death rates associated with prescribed and illicit benzodiazepine exposure among people receiving opioid-agonist treatment in Scotland, 2015 to 2020
BACKGROUND: Opioid agonist treatment (OAT) reduces mortality among individuals with opioid dependence. Benzodiazepine co-prescribing with OAT has previously been associated with increased rates of drug-related death (DRD). In Scotland, rising DRD rates have coincided with increasing detection of illicit benzodiazepines at post-mortem. We quantified DRD rates associated with prescribed and baseline self-reported illicit benzodiazepine exposure amo…
Medicine (9 obras) · Internal Medicine (7 obras) · HIV, Drug Use, Sexual Risk (6 obras) · Environmental health (5 obras) · Psychiatry (5 obras) · Virology (5 obras) · Demography (4 obras) · Harm reduction (4 obras) · Hepatitis C virus research (4 obras) · Logistic regression (4 obras)